Literature DB >> 11756608

Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation.

B Abou-Khalil1, Q Ge, R Desai, R Ryther, A Bazyk, R Bailey, J L Haines, J S Sutcliffe, A L George.   

Abstract

BACKGROUND: Generalized epilepsy with febrile seizures plus (GEFS+) is an autosomal dominant syndrome characterized by febrile seizures (FS) and a variety of afebrile generalized seizure types. GEFS+ has previously been linked to mutations in two genes encoding the voltage-gated sodium channel alpha-subunit (SCN1A) and beta1-subunit (SCN1B). We studied a large family with FS and partial as well as generalized seizure types.
METHODS: All but two living affected family members were interviewed and examined. Information on deceased affected family members was sought. EEG for 11 affected family members and one unaffected family member were obtained. Genetic linkage analysis and mutation screening of SCN1A were performed on blood samples from 16 affected individuals and their first-degree relatives.
RESULTS: There were 27 affected family members; 18 were alive at the time of the study. All affected family members had FS; seven had FS only, and 19 also had afebrile seizures. Eleven individuals continued to have FS beyond 6 years of age. FS were complex in 12 family members, usually with prolonged duration. The index patient had right temporal lobe epilepsy and hippocampal sclerosis. Four other patients had strong historical evidence of temporal lobe epilepsy, and three others had nonlocalizing evidence of partial epilepsy. Pedigree analysis indicated autosomal dominant transmission. All affected individuals who were tested and one asymptomatic individual had a sodium channel mutation of SCN1A, an A-->C transversion at nucleotide 3809 resulting in the substitution of lysine 1270 by threonine in the D3/S2 segment (designated as K1270T).
CONCLUSIONS: Our findings indicate that partial epilepsy preceded by FS can be associated with sodium channel mutations and may represent a variant of GEFS+.

Entities:  

Mesh:

Year:  2001        PMID: 11756608     DOI: 10.1212/wnl.57.12.2265

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

1.  Enteroviruses in chronic fatigue syndrome: "now you see them, now you don't".

Authors:  M C Dalakas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

2.  Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping.

Authors:  Mike E Weale; Chantal Depondt; Stuart J Macdonald; Alice Smith; Poh San Lai; Simon D Shorvon; Nicholas W Wood; David B Goldstein
Journal:  Am J Hum Genet       Date:  2003-07-29       Impact factor: 11.025

Review 3.  Sodium channel mutations in epilepsy and other neurological disorders.

Authors:  Miriam H Meisler; Jennifer A Kearney
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 4.  Inherited disorders of voltage-gated sodium channels.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

5.  The genetics of temporal lobe epilepsy and implications for treatment.

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2007 Jul-Aug       Impact factor: 7.500

6.  Generalised epilepsy with febrile seizures plus (GEFS(+)): molecular analysis in a restricted area.

Authors:  Agata Polizzi; Gemma Incorpora; Piero Pavone; Martino Ruggieri; Grazia Annesi; Antonio Gambardella; Lorenzo Pavone; Aldo Quattrone
Journal:  Childs Nerv Syst       Date:  2011-10-20       Impact factor: 1.475

7.  SCN1A and Febrile Seizures in Mesial Temporal Epilepsy: An Early Signal to Guide Prognosis and Treatment?

Authors:  Marvin A Rossi
Journal:  Epilepsy Curr       Date:  2014-07       Impact factor: 7.500

8.  Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.

Authors:  Ryan J Schutte; Soleil S Schutte; Jacqueline Algara; Eden V Barragan; Jeff Gilligan; Cynthia Staber; Yiannis A Savva; Martin A Smith; Robert Reenan; Diane K O'Dowd
Journal:  J Neurophysiol       Date:  2014-05-07       Impact factor: 2.714

9.  Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.

Authors:  Sarah K Bergren; Elizabeth D Rutter; Jennifer A Kearney
Journal:  Mamm Genome       Date:  2009-06-10       Impact factor: 2.957

Review 10.  Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction.

Authors:  Ethan M Goldberg; Douglas A Coulter
Journal:  Nat Rev Neurosci       Date:  2013-04-18       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.